Bio-Key International Inc (BKYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -782 | -205 | -7,158 | -2,869 | -1,904 |
| Depreciation Amortization | 265 | 132 | 812 | 590 | 410 |
| Income taxes - deferred | N/A | N/A | 17 | N/A | N/A |
| Accounts receivable | -285 | -353 | -253 | 9 | -15 |
| Accounts payable and accrued liabilities | -96 | 2 | -311 | -162 | 71 |
| Other Working Capital | 185 | -260 | -316 | -617 | -73 |
| Other Operating Activity | -490 | 326 | 2,540 | 210 | -205 |
| Operating Cash Flow | $-1,204 | $-358 | $-4,669 | $-2,838 | $-1,715 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | -7 | -6 |
| Investing Cash Flow | $N/A | $N/A | $-12 | $-7 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,000 | N/A | N/A |
| Debt Repayment | -38 | -38 | -146 | -109 | -72 |
| Common Stock Issued | 8 | N/A | 6,977 | 3,813 | 3,814 |
| Other Financing Activity | 0 | 0 | -918 | 752 | -249 |
| Financing Cash Flow | $-31 | $-38 | $6,912 | $4,456 | $3,494 |
| Exchange Rate Effect | -81 | -51 | 26 | -8 | 66 |
| Beginning Cash Position | 2,695 | 2,695 | 438 | 438 | 438 |
| End Cash Position | 1,379 | 2,248 | 2,695 | 2,040 | 2,275 |
| Net Cash Flow | $-1,315 | $-447 | $2,257 | $1,602 | $1,838 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,204 | -358 | -4,669 | -2,838 | -1,715 |
| Capital Expenditure | N/A | N/A | -12 | -7 | -6 |
| Free Cash Flow | -1,204 | -358 | -4,681 | -2,846 | -1,721 |